Modern Cell & Tissue Technologies Inc. – Trademark Portfolio
Entity Type: 03
Modern Cell & Tissue Technologies Inc. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 2 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include KERASKIN. The owner is based in Gangnam-gu, Seoul.
Gangnam-gu, Seoul 135-010 , KR
Showing of trademarks Trademarks
Trademark Classifications
Modern Cell & Tissue Technologies Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Modern Cell & Tissue Technologies Inc. have?
Modern Cell & Tissue Technologies Inc. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 cancelled.
What trademark classes does Modern Cell & Tissue Technologies Inc. file in?
Modern Cell & Tissue Technologies Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Modern Cell & Tissue Technologies Inc.'s most well-known trademarks?
Modern Cell & Tissue Technologies Inc.'s registered trademark portfolio includes well-known marks such as KERASKIN. These are among 1 currently registered trademark in the portfolio.
What is Modern Cell & Tissue Technologies Inc.'s trademark registration success rate?
Modern Cell & Tissue Technologies Inc. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.